Evaluation of somatostatin-receptor scintigraphy for detecting neuroendocrine tumors

Surgery
J B MekoJ A Norton

Abstract

Somatostatin-receptor scintigraphy (SRS) has gained attention as an imaging modality for neuroendocrine tumors (NETs). The purpose of this study was to present one of the first American series evaluating the ability of SRS to detect local and distant disease caused by NETs. Medical records were reviewed from 35 patients who underwent a total of 38 studies using 111In-pentetreotide between 1993 and 1995. Twenty-two patients had islet cell tumors, seven had carcinoid tumors, and six had other NETs. The overall sensitivity of SRS was 74% for detecting local disease (primary tumor +/- regional lymph node metastases) in all NETs, excluding insulinoma, 75% in gastrinoma, 0% in insulinoma, 78% in other islet cell tumors, and 50% in carcinoids. For detecting distant disease, the overall sensitivity of SRS was 67% for all NETs, excluding insulinoma, 100% for gastrinoma, 50% for other islet cell tumors, and 80% for carcinoids. Specificity and positive predictive value were 100% for all tumors. Negative predictive value ranged from 33% to 100%. A positive SRS study strongly predicts the presence of tumor (100% positive predictive value in our study). However, unlike the European reports of very high sensitivity (80% to 88%), we found that...Continue Reading

References

Jan 3, 1985·The New England Journal of Medicine·P N MatonR T Jensen
Nov 1, 1993·Pharmacology & Therapeutics·G WeckbeckerC Bruns
Jan 1, 1993·Digestion·S W LambertsE P Krenning
Jul 1, 1993·World Journal of Surgery·M A ZeigerJ A Norton
Apr 1, 1993·European Journal of Nuclear Medicine·D J KwekkeboomS W Lamberts

❮ Previous
Next ❯

Citations

Jul 14, 2007·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·U Hopt, T Keck
Sep 4, 2004·Current Treatment Options in Gastroenterology·James M. McLoughlinJeffrey T. Lamont
Apr 14, 2004·Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver·F Gibril, R T Jensen
Aug 30, 2003·Surgical Oncology·Gerard M Doherty
Jan 16, 1999·Clinical Nuclear Medicine·B D Nguyen, E A Wang
Feb 9, 2005·Journal of Pediatric Gastroenterology and Nutrition·Patrizia Dall'IgnaGiovanni Cecchetto
Jul 27, 2001·Current Opinion in Pulmonary Medicine·A L ChanK Y Yoneda
May 13, 2005·Gut·J K RamageUNKNOWN UKNETwork for Neuroendocrine Tumours
Nov 5, 2011·Gut·John K RamageUNKNOWN UK and Ireland Neuroendocrine Tumour Society
Jul 11, 2007·World Journal of Surgical Oncology·Steve L HyerClive L Harmer
Sep 13, 2007·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Charles M IntenzoEdith P Mitchell
Jul 18, 2006·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Ellen M ChungRichard M Conran
Dec 5, 2013·Advances in Surgery·Geoffrey W Krampitz, Jeffrey A Norton
Feb 19, 2005·Journal of Surgical Oncology·Gerard M Doherty
Feb 19, 2005·Journal of Surgical Oncology·Maria A KouvarakiDouglas B Evans
Dec 13, 2012·Journal of Clinical Ultrasound : JCU·Hye Soo KooYong-Koo Park
Nov 3, 2010·Journal of the American College of Surgeons·Anthony J ChambersOtto Rorstad
Jul 15, 2004·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·G BekeleI A Shah
May 11, 1999·The American Journal of Gastroenterology·T SaifuddinB Banerjee
Nov 7, 2003·The Journal of Clinical Endocrinology and Metabolism·J BertheratJ Epelbaum
May 21, 2003·Journal of Internal Medicine·G M Doherty, N W Thompson
Jul 12, 2017·Oncology Letters·Dawei HaoXiaowen Hao

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenoma, Islet Cell

Islet Cell Adenoma arises in the islet cells, which are insulin producing cells of the pancreas. These tumors can be either malignant or benign. Discover the latest research on Islet Cell Adenoma here.